Table 3.
Baseline characteristics of patients who survived through the study and died during the study
| Survived | Died | All | P value | |
|---|---|---|---|---|
| n (%) | 368 (87) | 57 (13) | 425 | |
| Age, yr | 56.2 ± 13.3 | 60.7 ± 13.3 | 56.8 ± 13.3 | 0.02 |
| Sex, % female | 41.6 | 47.4 | 42.3 | 0.41 |
| Body mass index, kg/m2 | 29.3 ± 7.1 | 28.5 ± 7.1 | 29.2 ± 7.1 | 0.44 |
| Albumin, mg/dl | 4.01 ± 0.34 | 3.85 ± 0.44 | 4.00 ± 0.36 | 0.001 |
| Pre-albumin, mg/dl | 29.8 ± 7.2 | 26.1 ± 7.9 | 29.3 ± 7.4 | 0.001 |
| Race, % | 0.47 | |||
| White | 14.7 | –a | 15.3 | |
| Black | 76.1 | 75.5 | 75.5 | |
| Other | 9.2 | –a | 9.2 | |
| Comorbidities, % | ||||
| Diabetes | 43.5 | 57.9 | 45.4 | 0.04 |
| Coronary artery disease | 7.6 | –a | 7.8 | 0.76 |
| Congestive heart failure | 15.8 | 17.5 | 16.0 | 0.73 |
| Frail | 26.4 | 49.1 | 29.4 | <0.001 |
a
Percentages suppressed because 1 or more categories contains <11 individuals.